Genomic and nongenomic effects of estrogen in the vasculature.
about
A developmental sex difference in hippocampal neurogenesis is mediated by endogenous oestradiolFunctional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma proteinFunctional implications of altered subcellular localization of PELP1 in breast cancer cells.Interactions between inflammation, sex steroids, and Alzheimer's disease risk factorsEstrogen-induced smooth muscle cell growth is regulated by tuberin and associated with altered activation of platelet-derived growth factor receptor-beta and ERK-1/2The role of estrogen receptor α and β in regulating vascular smooth muscle cell proliferation is based on sexExperimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.Sex-related decrease in [Ca2+]i signaling and Ca2+-dependent contraction in inferior vena cava of female rat.Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vesselsPotential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.Reproductive senescence blunts response of estrogen receptor-α expression to estrogen treatment in rat post-ischemic cerebral microvessels.Nongenomic inhibition of coronary constriction by 17ß-estradiol, 2-hydroxyestradiol, and 2-methoxyestradiol.Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular DiseaseSex hormones as potential modulators of vascular function in hypertension.Gender-specific reduction in contraction is associated with increased estrogen receptor expression in single vascular smooth muscle cells of female rat.Trafficking of peripheral blood CD56(bright) cells to the decidualizing uterus--new tricks for old dogmas?Alpha-adrenergic control of blood flow during exercise: effect of sex and menstrual phase.Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.17β-Estradiol-induced interaction of ERα with NPPA regulates gene expression in cardiomyocytes.Going nuclear in metabolic and cardiovascular diseaseReversible posterior leukoencephalopathy syndrome induced by pazopanib.Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status.Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]I in mesenteric microvessels of female rat.Gender differences in cardiovascular disease: hormonal and biochemical influences.Gender differences in hepatic ischemic reperfusion injury in rats are associated with endothelial cell nitric oxide synthase-derived nitric oxide.Chronic treatment of male rats with daidzein and 17 beta-oestradiol induces the contribution of EDHF to endothelium-dependent relaxation.Estrogen receptor-β and fetoplacental endothelial prostanoid biosynthesis: a link to clinically demonstrated fetal growth restriction.Vascular effects of estrogenic menopausal hormone therapy.17Beta-estradiol effects on human coronaries and grafts employed in myocardial revascularization: a preliminary study.Trafficking of circulating pro-NK cells to the decidualizing uterus: regulatory mechanisms in the mouse and humanVascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular diseaseRapid activation of nuclear factor κB by 17β-estradiol and selective estrogen receptor modulators: pathways mediating cellular protection.Role of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry.Adaptive increases in expression and vasodilator activity of estrogen receptor subtypes in a blood vessel-specific pattern during pregnancy.Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferationTherapeutic implications of the gender-specific aspects of cardiovascular disease.Estrogen signaling multiple pathways to impact gene transcription.
P2860
Q21195891-96EAA65B-96DA-4377-B709-5D08A353F610Q24534448-B4E01F94-36D2-401B-AA4A-A9B0735A3C1FQ28270490-BADD2D45-6647-4CF0-81AF-AB7CA81BF4C9Q28394967-617D37EC-FEAD-40D6-B386-EA265E952FFBQ28564379-DA4479D6-732F-4FCF-B4A7-5548706472A7Q28578896-BB8B0F50-5E53-486A-9CE4-2DC11AFCA97AQ33572292-0A77D207-2121-4225-969A-7652B5C74310Q33589517-634D6B8C-2BA2-4831-968A-08F3D70C349CQ33761774-9E145D29-5E86-491C-8AC4-D6D126C4C1FDQ33781367-C93E4CBF-C51C-4478-B07C-F1EC53A9DABAQ33786755-9FE9F179-B6A7-4709-BA89-DDD5A1C50835Q33882546-90CB4D2C-A487-45A7-8E72-FBAF4FCE4DE4Q34021692-744ECD78-A745-40E1-BF7A-0CF4ABB1836AQ34043346-21DCE0BC-C7E2-4CAD-81C6-870F6D7A2BDFQ34074830-05FD9966-B335-407A-9064-B87CA1410913Q34090934-FD27281B-D9A4-4288-84A0-DBE7EA48D35EQ34258306-EA726CDF-AA05-49DE-8647-124D87C43282Q34305319-BF3F9967-E709-41DD-B2DF-09B1CDE403E3Q34375771-8483BF4B-6BEA-4DBF-899C-28B2A081FB15Q34409624-331B05FC-420F-456B-8BAC-CDFA433DB2FFQ34416412-CCC5E9AE-BD48-4C1A-81AC-6B3C6EC49143Q34454240-E7BA0ADC-2EA2-4F1E-A2E2-DC9A7B765037Q34524900-A166B8C0-7941-40A3-91BD-5C780D1C9158Q34712250-E891FACC-642F-46C9-BB5B-F31EC61BDCAAQ34762218-F1825196-DC67-43E6-9088-56DE01A0891BQ34946607-44E09387-2884-4F0C-8755-D29316522DB6Q35023822-B8AEDCAB-F2BB-4B57-BA0D-859A19C5237CQ35045391-A15BDAC9-6A44-4073-BF3B-3EADA06AF5C5Q35046062-0B3FDFFC-B310-45C5-99F4-2F7EFE26E75DQ35432967-1197638C-5F7F-4DC0-B9BD-1FAE4F02713DQ35583311-A2852E46-0B22-4C1A-B7CD-E9364A265FF9Q35589198-F62F253E-3B2E-40A7-B56E-78A24DC83177Q35777472-E315A888-9A7E-437E-A3B6-160C7510122EQ35783517-1A225132-0EBE-4208-83FD-10C6BD3E5CF2Q36107305-F73ECF32-471B-43DB-A051-E07137A64E34Q36118240-8F01CC56-C25A-4705-935A-50B38C3D7B32Q36339474-9785345E-4FF2-47C6-A475-15D8A0373DE3Q36441837-963CE454-4C7E-43BB-B2B9-8B2E9D4E33B0Q36467824-CB50B84D-E08B-405F-8FB0-62EA7C2C223EQ36499769-191D7D1E-D2BC-42B9-9A27-BD021A8121BA
P2860
Genomic and nongenomic effects of estrogen in the vasculature.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Genomic and nongenomic effects of estrogen in the vasculature.
@ast
Genomic and nongenomic effects of estrogen in the vasculature.
@en
Genomic and nongenomic effects of estrogen in the vasculature.
@nl
type
label
Genomic and nongenomic effects of estrogen in the vasculature.
@ast
Genomic and nongenomic effects of estrogen in the vasculature.
@en
Genomic and nongenomic effects of estrogen in the vasculature.
@nl
prefLabel
Genomic and nongenomic effects of estrogen in the vasculature.
@ast
Genomic and nongenomic effects of estrogen in the vasculature.
@en
Genomic and nongenomic effects of estrogen in the vasculature.
@nl
P1476
Genomic and nongenomic effects of estrogen in the vasculature.
@en
P2093
Michael E Mendelsohn
P356
10.1016/S0002-9149(02)02418-9
P407
P577
2002-07-01T00:00:00Z